Clinical Trials Browser

Phase 2 × Radiodermatitis × Biafine × Clear all

NCT02729324 2016-04-06

Comparison of Efficacy and Safety Between Medical Radiation Protectants (FORRAD®) and Trolamine (Biafine) for the Management of Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma Receiving IMRT

Phase 2 Unknown

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Radiodermatitis